“Right to Try” laws aim to boost access to unapproved therapies, but hurdles and safety concerns linger.
Source link
Longevity Firms Push Montana to Become Hub for Biohacking, Experimental Treatments
Related Posts
The year AI tech giants, and billions in debt, began remaking America
The Stargate AI knowledge heart in Abilene, Texas, US, on Wednesday, Sept. 24, 2025. Kyle Grillot | Bloomberg | Getty…
BioMarin to Buy Rare-Disease Biotech Amicus Therapeutics for $4.8 Billion
BioMarin Pharmaceutical has struck a deal to purchase fellow biotechnology firm Amicus Therapeutics for about $4.8 billion in money. Source…
Malicious Traffic Surges 245% Since Iran War Began
Malicious visitors has surged worldwide for the reason that Iran battle started, exposing rising dangers from coordinated assaults, reconnaissance, and…